| Market revenue in 2024 | USD 208.4 million |
| Market revenue in 2030 | USD 556.1 million |
| Growth rate | 18.8% (CAGR from 2025 to 2030) |
| Largest segment | Filtration |
| Fastest growing segment | Cell Culture & Mixing |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish Applications, Other Applications |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Sartorius AG, Danaher Corp, Avantor Inc, Lonza Group Ltd, Compagnie de Saint-Gobain SA, Corning Inc, Entegris Inc, Kuhner Shaker |
Australia’s excellent research facilities, world-class researchers, and a firm but flexible regulatory framework have made it a powerhouse of pharmaceutical and biotechnology innovation. According to the data published by the Australian Trade and Investment Commission, Australia has become a hub for a thriving network of more than 470 biotechnology companies.
The significant presence of established pharmaceutical & biotechnology companies and extensive R&D initiatives being undertaken by them are expected to create high demand for single-use systems in the country.
Single-use assemblies aid in reducing costs associated with complex steps such as maintenance of steel-based bioreactors & accessories, cleaning, and sterilization. The application of single-use assemblies significantly helps in reducing the R&D costs and initial investments involved in the production of biologics.
Publish Date: May 05, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Sartorius AG | View profile | 14,338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | www.sartorius.com |
| Avantor Inc | View profile | 14,500 | 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 | www.avantorsciences.com |
| Compagnie de Saint-Gobain SA | View profile | 168,508 | 12, Place de l'Iris, Tour Saint-Gobain, Courbevoie, France, 92400 | www.saint-gobain.com |
| Corning Inc | View profile | 49,800 | One Riverfront Plaza, Corning, NY, United States, 14831 | www.corning.com |
| Entegris Inc | View profile | 8,000 | 129 Concord Road, Billerica, MA, United States, 01821 | www.entegris.com |
| Kuhner Shaker | View profile | 11-50 | Birsfelden, Basel-Landschaft, Switzerland, Europe | kuhner.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Use Assemblies Market Outlook will help companies and investors design strategic landscapes.
Filtration was the largest segment with a revenue share of 32.68% in 2024.
Horizon Databook has segmented the Australia single use assemblies market based on filtration, cell culture & mixing, storage, sampling, fill-finish applications, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
Australia’s excellent research facilities, world-class researchers, and a firm but flexible regulatory framework have made it a powerhouse of pharmaceutical and biotechnology innovation. According to the data published by the Australian Trade and Investment Commission, Australia has become a hub for a thriving network of more than 470 biotechnology companies.
The significant presence of established pharmaceutical & biotechnology companies and extensive R&D initiatives being undertaken by them are expected to create high demand for single-use systems in the country.
Single-use assemblies aid in reducing costs associated with complex steps such as maintenance of steel-based bioreactors & accessories, cleaning, and sterilization. The application of single-use assemblies significantly helps in reducing the R&D costs and initial investments involved in the production of biologics.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Single Use Assemblies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Single Use Assemblies Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
